Cel Sci CVM
NYSE CVM
$2.08 +0.02 (+0.73%)
As of: Oct 1, 2026 · 3:59 PM EDT

Cel Sci (CVM) Depreciation & Amortization - Total (2010 - 2015)

Updated

Cel Sci's Depreciation & Amortization - Total was $28,309 in fiscal Q1 2016 (quarter ended Dec 31, 2015), down 34.4% from $43,159 a year earlier and down 75.2% from the prior quarter.

Analysis

Cel Sci (CVM) Depreciation & Amortization - Total (2010 - 2015) Analysis & Trends

On a trailing twelve-month basis, Cel Sci's Depreciation & Amortization - Total was $134,089 through Dec 31, 2015, down 22.9% year-over-year; for FY2015 (ended Sep 30, 2015), it came in at $148,939, down 13.6% from FY2014.

  • Depreciation & Amortization - Total has now declined for three consecutive fiscal years, with a five-year compound annual growth rate of -19.3% (FY2010 to FY2015).
  • In earlier fiscal years, Depreciation & Amortization - Total was $172,442 in FY2014 (-31.9%), $253,072 in FY2013 (-43.2%), $445,710 in FY2012 (+1.6%) and $438,738 in FY2011 (+1.1%).
  • Quarterly Depreciation & Amortization - Total has moved between -$49,035 (fiscal Q3 2015) and $123,519 (fiscal Q3 2011) over five years.
  • Compared with a year earlier, Depreciation & Amortization - Total was higher in three of the last seven quarters, with growth averaging 12.5%.
  • The best year-over-year quarter for Depreciation & Amortization - Total over five years was fiscal Q4 2015 (growth of 152.2%); the worst was fiscal Q1 2014 (a decline of 60.3%).
  • Per Business Quant data, CVM's Depreciation & Amortization - Total in the three fiscal quarters before Q1 2016 was $113,930 (Q4 2015), -$49,035 (Q3 2015) and $40,885 (Q2 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Cel Sci 3.69 Mn -21.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 28,309.00
Sep 30, 2015 113,930.00
Jun 30, 2015 -49,035.00
Mar 31, 2015 40,885.00
Dec 31, 2014 43,159.00
Sep 30, 2014 45,174.00
Jun 30, 2014 43,877.00
Mar 31, 2014 41,718.00
Dec 31, 2013 41,673.00
Sep 30, 2013 44,322.00
Jun 30, 2013 47,931.00
Mar 31, 2013 55,957.00
Dec 31, 2012 104,864.00
Sep 30, 2012 107,360.00
Jun 30, 2012 109,867.00
Mar 31, 2012 108,531.00
Dec 31, 2011 114,612.00
Sep 30, 2011 79,395.00
Jun 30, 2011 123,519.00
Mar 31, 2011 119,633.00
API Access

Cel Sci Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=CVM&period=max&api_key=YOUR_API_KEY